InsiderClue
← All stocks

Acrivon Therapeutics, Inc.

ACRV Net buying
CIK 0001781174 #4343 in the set updated 17 Sep 2026
Bought (120 mo)
$67.48M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.90M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$3.90M
19 of 19 sales
Net
+$63.58M
+$63.58M against sales at will

By person

20 insiders · 29 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$42.37M (1)
—
+$42.37M
9,366
0.0219%
$20.67K
—
PERCEPTIVE ADVISORS LLC entity
10% owner
$20.00M (1)
$3.76M (5)
+$16.24M
3,104,139
7.24%
$6.85M
+3.2%
Chione Ltd entity
10% owner
$5.00M (1)
$97.58K (5)
+$4.90M
3,848,632
8.98%
$8.49M
—
Blume-Jensen Peter
President and CEO
$82.12K (1)
$34.41K (3)
+$47.71K
2,615,911
6.10%
$5.77M
+125.0%
Devroe Eric
Chief Operating Officer
$17.22K (1)
$1.21K (1)
+$16.00K
146,349
0.3415%
$322.90K
+621.8%
Levy Adam D.
Chief Financial Officer
$15.00K (1)
$1.79K (1)
+$13.21K
66,008
0.1540%
$145.64K
+395.7%
Miller Mary
Chief Legal Officer
—
$1.38K (2)
−$1.38K
82,009
0.1914%
$180.94K
+102.8%
Gamelin Erick
Chief Development Officer
—
$804.00 (1)
−$804.00
52,592
0.1227%
$116.04K
—
Peterson Katharine
Chief Accounting Officer
—
$203.01 (1)
−$203.01
18,033
0.0421%
$39.79K
+273.2%
Masson Kristina
EVP - Business Operations
—
—
—
2,687,343
6.27%
$5.93M
+130.5%
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
888,130
2.07%
$1.96M
—
Mirza Mansoor Raza
Chief Medical Officer
—
—
—
38,817
0.0906%
$85.65K
—
Levin Michaela
Chief Business Officer
—
—
—
30,000
0.0700%
$66.19K
—
Holm-Jorgensen Rasmus
Chief Financial Officer
—
—
—
26,088
0.0609%
$57.56K
—
DiRocco Derek
Director
—
—
—
9,366
0.0219%
$20.67K
—
Palani Santhosh
Director
—
—
—
9,366
0.0219%
$20.67K
—
Magovcevic-Liebisch Ivana
Director
—
—
—
9,366
0.0219%
$20.67K
—
TOMSICEK MICHAEL JOHN
Director
—
—
—
9,366
0.0219%
$20.67K
—
Shacham Sharon
Director
—
—
—
9,366
0.0219%
$20.67K
—
BAUM CHARLES M
Director
—
—
—
9,366
0.0219%
$20.67K
—

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Blume-Jensen Peter
25 Aug 2026
President and CEO
Sell
14,036
$2.21
$30.97K
Blume-Jensen Peter
18 Aug 2026
President and CEO
Sell indirect
484
$2.01
$972.84
Blume-Jensen Peter
18 Aug 2026
President and CEO
Sell
1,229
$2.01
$2.47K
Devroe Eric
18 Aug 2026
Chief Operating Officer
Sell
604
$2.01
$1.21K
Gamelin Erick
18 Aug 2026
Chief Development Officer
Sell
400
$2.01
$804.00
Miller Mary
18 Aug 2026
Chief Legal Officer
Sell
185
$2.01
$371.85
Peterson Katharine
18 Aug 2026
Chief Accounting Officer
Sell
101
$2.01
$203.01
Levy Adam D.
4 Aug 2026
Chief Financial Officer
Sell
1,142
$1.57
$1.79K
Miller Mary
21 Jul 2026
Chief Legal Officer
Sell
573
$1.76
$1.01K
PERCEPTIVE ADVISORS LLC
1 May 2025
10% owner
Sell indirect
298,886
$1.34
$400.51K
PERCEPTIVE ADVISORS LLC
30 Apr 2025
10% owner
Sell indirect
437,881
$1.41
$617.41K
PERCEPTIVE ADVISORS LLC
29 Apr 2025
10% owner
Sell indirect
250,000
$1.41
$352.50K
PERCEPTIVE ADVISORS LLC
28 Apr 2025
10% owner
Sell indirect
215,283
$1.56
$335.84K
PERCEPTIVE ADVISORS LLC
25 Apr 2025
10% owner
Sell indirect
1,054,669
$1.95
$2.06M
Chione Ltd
26 Jun 2023
10% owner
Sell
16
$12.93
$206.88
Chione Ltd
15 Jun 2023
10% owner
Sell
2,056
$12.14
$24.96K
Chione Ltd
14 Jun 2023
10% owner
Sell
893
$12.13
$10.83K
Chione Ltd
13 Jun 2023
10% owner
Sell
3,000
$12.30
$36.90K
Chione Ltd
12 Jun 2023
10% owner
Sell
2,000
$12.34
$24.68K
Show all 29 transactions →

What was left out

Form 4 filings counted 182
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 37
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 18,397,067
History held since 16 Nov 2022